Los Angeles, CA (July 13, 2017) Many women are turning to egg freezing to promote fertility, but what happens when it isn't an option because of special medical or other conditions? And, what option is there for women who want to preserve hormonal function, not just fertility? Ovarian tissue freezing, an outpatient procedure which removes and freezes ovarian tissue for later use, can deliver these outcomes but has been considered experimental until now. According to a new study, nearly four out of 10 (37.7%) women who undergo the procedure are able to have children later in life as a result. This study is out today in Reproductive Sciences , a SAGE Publishing journal.
"Despite the clinical progress within the past two decades, the procedure still remains in the experimental realm," wrote Pacheco and Oktay. "Now, women considering this procedure to preserve fertility and postpone childbearing have more information at their disposal. Given these recent data, ovarian tissue cryopreservation should be considered as a viable option for fertility preservation."
To assess the state and success rate of this procedure, Dr. Kutluk Oktay, who performed the world's first procedure of this kind in 1999, examined data from 1999 to 2016, together with his study co-author, Dr. Fernanda Pacheco. They found that:
"The procedure is superior to egg freezing as it can also reverse menopause and restore natural fertility," continued the senior study author Dr. Oktay. "The next frontier is to explore the procedure's potential in delaying childbearing among health women, not just cancer patients."
###
Find out more by reading the full article, "Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis," by Fernanda Pacheco and Kutluk Oktay, in Reproductive Sciences . For an embargoed copy of the full text, please email tiffany.medina@sagepub.com .
Sara Miller McCune founded SAGE Publishing in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE is a leading international provider of innovative, high-quality content publishing more than 1,000 journals and over 800 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company's continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. http://www.sagepublishing.com
Reproductive Sciences (RS) is a peer-reviewed, monthly journal publishing original research and reviews in obstetrics and gynecology. RS is multi-disciplinary and includes research in basic reproductive biology and medicine, maternal-fetal medicine, obstetrics, gynecology, reproductive endocrinology, urogynecology, fertility/infertility, embryology, gynecologic/reproductive oncology, developmental biology, stem cell research, molecular/cellular biology and other related fields. Average time from submission to first decision: 34 days. journals.sagepub.com/home/rsxb
Contact:
(US) Tiffany Medina tiffany.medina@sagepub.com / Tel: 805-410-7441
(UK) Mollie Broad mollie.broad@sagepub.co.uk / Tel: +44 (0)20 73248782
Reproductive Sciences